HBV and HCV serological monitoring among injection drugs users in opiate substitution treatment in Bosnia and Herzegovina | Zendy

Siniša Skočibušić | Zendy; Marko Martinac | Zendy; Jurica Arapović | Zendy; Svjetlana Grgić | Zendy; Jadranka Nikolić | Zendy; Dino Hasanagić | Zendy; Milenko Bevanda | Zendy; Jelena Ravlija | Zendy

Open Access

HBV and HCV serological monitoring among injection drugs users in opiate substitution treatment in Bosnia and Herzegovina

Author(s) -

Siniša Skočibušić,

Marko Martinac,

Jurica Arapović,

Svjetlana Grgić,

Jadranka Nikolić,

Dino Hasanagić,

Milenko Bevanda,

Jelena Ravlija

Publication year - 2016

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.7445

Subject(s) - medicine , paraphernalia , seroprevalence , hbsag , heroin , hepatitis c , hepatitis c virus , serology , hepatitis b , hepatitis b virus , virology , needle sharing , syphilis , immunology , virus , drug , antibody , pharmacology , human immunodeficiency virus (hiv) , condom , archaeology , history

Use of intravenous heroin carries a risk of serious medical conditions, including acquiring blood-borne infections. Therefore, hepatitis B virus (HBV) and hepatitis C virus (HCV) infection represent a threat for people who inject drugs (PWID). The objectives of this study were to determine the extent and characteristics of risk factors for acquiring HBV and HCV infection in PWID included in opiate substitution treatment in the southern part of Bosnia and Herzegovina (B&H).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research